Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimization
R. B. Verheijen, L. E. Swart, J. H. Beijnen, J. H.M. Schellens, A. D.R. Huitema, N. Steeghs
Research output: Contribution to journal › Article › peer-review
51Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimization'. Together they form a unique fingerprint.